Shandong Keyuan Pharmaceutical Co (SZSE:301281) E10: ¥0.64 (As of Mar. 2026)


SZSE:301281 Shandong Keyuan Pharmaceutical Co Ltd SZSE:301281
67 GF Score
Price ¥46.62
GF Value ¥30.42
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Shandong Keyuan Pharmaceutical Co E10?

Shandong Keyuan Pharmaceutical Co SZSE:301281 -7.54% 67 E10 is ¥0.64 as of Mar. 2026. GuruFocus rates SZSE:301281 with a GF Score™ of 67/100 and a GF Value™ of ¥30.42 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shandong Keyuan Pharmaceutical Co's adjusted earnings per share data for the fiscal year that ended in Dec. 2025 was ¥0.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.64 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average E10 Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shandong Keyuan Pharmaceutical Co was 1.60% per year. The lowest was 1.60% per year. And the median was 1.60% per year.

As of today (2026-07-13), Shandong Keyuan Pharmaceutical Co's current stock price is ¥ 46.62. Shandong Keyuan Pharmaceutical Co's E10 for the fiscal year that ended in Dec. 2025 was ¥0.64. Shandong Keyuan Pharmaceutical Co's Shiller PE Ratio of today is 72.84.

During the past 13 years, the highest Shiller PE Ratio of Shandong Keyuan Pharmaceutical Co was 78.74. The lowest was 35.78. And the median was 47.97.


Shandong Keyuan Pharmaceutical Co  (SZSE:301281) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shandong Keyuan Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=46.62/0.64
=72.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shandong Keyuan Pharmaceutical Co was 78.74. The lowest was 35.78. And the median was 47.97.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shandong Keyuan Pharmaceutical Co E10 Related Terms


Shandong Keyuan Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Shandong Keyuan Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Keyuan Pharmaceutical Co E10 Chart

Shandong Keyuan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.61 0.63 0.66 0.64

Shandong Keyuan Pharmaceutical Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.64 0.00

SZSE:301281 vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, Shandong Keyuan Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Keyuan Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Keyuan Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Keyuan Pharmaceutical Co's Shiller PE Ratio falls into.


SZSE:301281
67GF Score
Shandong Keyuan Pharmaceutical Co Ltd SZSE:301281
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Keyuan Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shandong Keyuan Pharmaceutical Co's adjusted earnings per share data for the fiscal year that ended in Dec. 2025 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.15/115.8323*115.8323
=0.150

Current CPI (Dec. 2025) = 115.8323.

Shandong Keyuan Pharmaceutical Co Annual Data

per_share_eps CPI Adj_EPS
201612 0.471 102.600 0.532
201712 0.571 104.500 0.633
201812 0.350 106.500 0.381
201912 0.371 111.200 0.386
202012 0.843 111.500 0.876
202112 0.964 113.108 0.987
202212 1.120 115.116 1.127
202312 0.760 114.781 0.767
202412 0.560 114.893 0.565
202512 0.150 115.832 0.150

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.64 mean?
Shandong Keyuan Pharmaceutical Co (SZSE:301281) has a E10 of ¥0.64 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors.
Is Shandong Keyuan Pharmaceutical Co's E10 too high?
Shandong Keyuan Pharmaceutical Co's current E10 is ¥0.64. Overall, Shandong Keyuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Keyuan Pharmaceutical Co's E10 compare to LLY and JNJ?
Shandong Keyuan Pharmaceutical Co's E10 of ¥0.64 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. Shandong Keyuan Pharmaceutical Co's current E10 is ¥0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Keyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co (SZSE:301281) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥30.42, compared to a current price of ¥46.62 — trading 53.3% above its estimated fair value. The current E10 is ¥0.64. Shandong Keyuan Pharmaceutical Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Shandong Keyuan Pharmaceutical Co (SZSE:301281), the current E10 is ¥0.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Keyuan Pharmaceutical Co (SZSE:301281) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥46.62 is trading 53.3% above its estimated GF Value™ of ¥30.42. GuruFocus considers Shandong Keyuan Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SZSE:301281:

  • E10: ¥0.64
  • GF Value™: ¥30.42 vs. price of ¥46.62 (53.3% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the SZSE:301281 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Keyuan Pharmaceutical Co Business Description

Address Keyuan Street, Shandong Shanghe Economic Development Zone, Shandong Province, Jinan, CHN, 251601
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
67GF Score

Get the complete analysis for SZSE:301281

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥46.62
Price
¥30.42
GF Value